Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: Implications for human immunodeficiency virus type one-associated dementia

Neuroscience Letters

Volumn 341, Issue 3, 2003, Pages 246-250

  Xiong, Huangui ^a,b   McCabe, Laura ^a,b   Skifter, Donald ^b   Monaghan, Daniel T ^b   Gendelman, Howard E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Human immunodeficiency virus; Macrophages; N methyl D aspartate receptor; Voltage clamp; Xenopus oocytes

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CD40 ANTIGEN; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECOMBINANT RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTRACELLULAR FLUID; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; NERVE CELL LESION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

EID: 0037426561     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00194-0     Document Type: Article

References (21)

1. Anderson E., Zink W., Xiong H., Gendelman H.E. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. JAIDS. 31:2002;S43-S54.
2. - channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J. Biol. Chem. 266:1991;19142-19145.
3. Budka H. Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol. 77:1989;225-236.
4. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
5. Epstein L.G., Gendelman H.E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechansims. Ann. Neurol. 33:1993;429-436.
6. Ferrarese C., Aliprandi A., Tremolizzo L., Stanzani L., De Micheli A., Dolara A., Frattola L. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology. 57:2001;671-675.
7. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., Burke D.S., Skillman D., Meltzer M.S. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1988;1428-1441.
8. Gurwitz D., Kloog Y. Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia. J. Am. Med. Assoc. 277:1997;1931.
9. Heyes M.P., Ellis R.J., Ryan L., Childers M.E., Grant I., Wolfson T., Archibald S., Jernigan T.L. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain. 124:2001;1033-1042.
10. Heyes M.P., Saito K., Lackner A., Wiley C.A., Achim C.L., Markey S.P. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J. 12:1998;881-896.
11. Janssen R.S., Cornblath D.R., Epstein L.G., Foa R.P., McArther J.C., Price R.W., Asbury A.K., Beckett A., Benson D.F., Bridge T.P., Leventhal C.M., Satz P., Saykin A., Sidtis J.J., Tross S. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 41:1991;778-785.
12. Jiang Z.G., Piggee C., Heyes M.P., Murphy C., Quearry B., Bauer M., Zheng J., Gendelman H.E., Markey S.P. Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J. Neuroimmunol. 117:2001;97-107.
13. Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:2001;988-994.
14. Muller W.E., Pergande G., Ushijima H., Schleger C., Kelve M., Perovic S. Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention. Prog. Mol. Subcell. Biol. 16:1996;44-57.
15. Nottet H.S., Flanagan E.M., Flanagan C.R., Gelbard H.A., Gendelman H.E., Reinhard J.F. Jr. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirol. 2:1996;111-117.
16. Pemberton L.A., Kerr S.J., Smythe G., Brew B.J. Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J. Interferon Cytokine Res. 17:1997;589-595.
17. Smith D.G., Guillemin G.J., Pemberton L., Kerr S., Nath A., Smythe G.A., Brew B.J. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J. Neurovirol. 7:2001;56-60.
18. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45:1993;309-379.
19. Toggas S.M., Masliah E., Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706:1996;303-307.
20. Ushijima H., Nishio O., Klocking R., Perovic S., Muller W.E. Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor- mediated neurotoxicity. Eur. J. Neurosci. 7:1995;1353-1359.
21. Xiong H., Zheng J., Thylin M., Gendelman H.E. Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res. Hum. Retroviruses. 15:1999;57-63.